Related Experiment Videos
Uveitopathogenic sites in recoverin
1Department of Ophthalmology, Akita University School of Medicine, 1-1-1, Hondo, Akita City, 010-8543, Japan.
Current Eye Research
|July 20, 2001
Summary
Researchers identified novel potent uveitopathogenic sites in recoverin, specifically amino acids 149-167. These findings advance understanding of uveitis pathogenesis and potential treatments.
Area of Science:
- Ophthalmology
- Immunology
- Molecular Biology
Background:
- Uveitis is an inflammatory eye disease with complex pathogenesis.
- Recoverin is a protein implicated in certain forms of uveitis.
Purpose of the Study:
- To identify potent and novel uveitopathogenic sites within the recoverin protein using synthetic peptides.
- To elucidate specific sequences responsible for inducing experimental autoimmune uveitis (EAU).
Main Methods:
- Synthetic peptides of the recoverin sequence were injected into Lewis rats.
- Uveitopathogenicity was assessed through clinical, histological, and immunological evaluations.
- Lymphocyte proliferation assays were performed to confirm immune responses.
Main Results:
- Peptides containing amino acids 57-85 and 136-167 induced severe EAU at low doses (20 µg and 10 µg, respectively).
- Core uveitopathogenic sequences were identified as 65-79 and 153-164.
- The smallest potent uveitopathogenic sequences identified were 65-79 and 149-167.
Conclusions:
- Recoverin possesses novel potent uveitopathogenic sites, particularly the 149-167 sequence.
- Identifying these sites enhances comprehension of uveitis pathogenesis.
- These findings may facilitate the development of targeted treatments for uveitis.